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ABSTRACT
Mitochondrial DNA depletion syndromes (MDS) are a group of rare
autosomal recessive disorders with early onset and no cure available.
MDS are caused by mutations in nuclear genes involved in
mitochondrial DNA (mtDNA) maintenance, and characterized by
both a strong reduction in mtDNA content and severe mitochondrial
defects in affected tissues. Mutations in MPV17, a nuclear gene
encoding a mitochondrial inner membrane protein, have been
associated with hepatocerebral forms of MDS. The zebrafish mpv17
null mutant lacks the guanine-based reflective skin cells named
iridophores and represents a promising model to clarify the role of
Mpv17. In this study, we characterized the mitochondrial phenotype of
mpv17−/− larvae and found early and severe ultrastructural alterations
in livermitochondria, aswell as significant impairment of the respiratory
chain, leading to activation of the mitochondrial quality control. Our
results provide evidence for zebrafish Mpv17 being essential for
maintaining mitochondrial structure and functionality, while its effects
on mtDNA copy number seem to be subordinate. Considering that a
role in nucleotide availability had already been postulated for MPV17,
that embryos blocked in pyrimidine synthesis do phenocopympv17−/−
knockouts (KOs) and thatmpv17−/−KOshave impairedDihydroorotate
dehydrogenase activity, we provided mpv17 mutants with the
pyrimidine precursor orotic acid (OA). Treatment with OA, an easily
available food supplement, significantly increased both iridophore
number andmtDNA content inmpv17−/−mutants, thus linking the loss
of Mpv17 to pyrimidine de novo synthesis and opening a new simple
therapeutic approach for MPV17-related MDS.
KEY WORDS: Dihydroorotate dehydrogenase, Iridophore,
Mitochondrial DNA depletion syndrome, Pyrimidine, Vitamin B13
INTRODUCTION
In the past few years, the scientific scenario identified
mitochondria as key players in a growing spectrum of human
diseases. Beside their main functions in oxidative phosphorylation
and bioenergetics, mitochondria also participate in a plethora of
cell pathways, such as apoptosis, production of reactive oxygen
species (ROS), heat generation and lipid metabolism (Wallace,
2005). Notably, mitochondrial functionality requires a synergistic
relationship between mitochondrial and nuclear genomes
(Chinnery and Hudson, 2013). In fact, mitochondrial DNA
(mtDNA) encodes only 13 subunits of the respiratory chain
(RC), while the remaining ∼1500 mitochondrial proteins, encoded
by nuclear DNA (nDNA), are imported into the organelle (Calvo
et al., 2016).
Each mitochondrion may contain hundreds of copies of mtDNA
and, considering that energy demand depends on age, tissue and life
style, even in physiological conditions, the amount of mtDNA
differs between cell types and individuals (Suomalainen and
Isohanni, 2010). What has become clear, however, is that
having the correct mtDNA amount in each tissue is crucial. In
fact, mtDNA depletion has been discovered to cause a continuously
increasing group of severe human diseases called mtDNA depletion
syndromes (MDS), first described in 1991 (Moraes et al., 1991).
MDS are a clinically heterogeneous group of autosomal-recessive
mitochondrial disorders, caused by mutations in nuclear genes,
such as MPV17, involved in mtDNA replication and maintenance.
Symptoms of MDS typically appear during infancy and childhood,
and are characterized by the reduction ofmtDNA copy number in the
affected tissues (Nogueira et al., 2014). MPV17 is an inner-
membrane mitochondrial protein possibly involved in mitochondrial
deoxynucleoside triphosphates (dNTP) pool homeostasis (Löllgen
and Weiher, 2014; Krauss et al., 2013). Mutations in the MPV17
gene are known to cause Navajo neurohepatopathy (NNH)
(Karadimas et al., 2006) and a hepatocerebral form of MDS
(Spinazzola et al., 2006). In fact, of∼50MPV17 pathogenic variants
reported worldwide in ∼100 patients, the c.149G>A (p.R50Q)
missense mutation has been found with an unusually high frequency
in NNH-affected individuals (El-Hattab et al., 2018). To date, the
precise function of MPV17 is unclear, even though many studies
have been carried out in different in vivomodels. Among those, two
spontaneous zebrafish mpv17 mutants, roy orbison (roy) and
transparent (tra), have been independently identified (Krauss
et al., 2013; D’Agati et al., 2017). Notably, although the genomic
lesions have not been properly sequenced so far in each mutant line,
they both lead to the same 19 bp deletion in the coding sequence,
originating from a defective splicing of intron 2. Both roy and tra
(mpv17−/−) display pigmentation abnormalities due to the lack of
cells derived from the neural crest, such as iridophores, and, at later
stages of development, melanophores (Krauss et al., 2013). Notably,
in vertebrates, neural crest cells migrate and give rise to a large
variety of complex structures, including peripheral nervous system,
part of the craniofacial skeleton and pigment cells (Kelsh et al.,
1996). In particular, the zebrafish pigment pattern presents three
distinct types of cells: black melanophores, yellow xantophores and
reflective iridophores, which strongly interact with each other and areReceived 20 September 2018; Accepted 25 February 2019
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distributed along longitudinal stripes and silvery/yellow
interstripes (Kelsh et al., 2017). Several zebrafish mutants
bearing recessive mutations in the de novo purine synthesis
genes gart and paics show defects in iridophores, the cells
containing light-reflective purine platelets, which are responsible
for the shiny appearance of the striped pattern (Frohnhöfer et al.,
2013; Ng et al., 2009).
In this work, we validated the functional homology between
human and zebrafish Mpv17 and improved the characterization
of the roy/tra phenotype, providing evidence of mitochondrial
defects, RC impairment and mtDNA depletion. Our findings
indicate roy and tra as valuable models for MPV17-related MDS.
Moreover, because the chemical inhibition of pyrimidine de novo
synthesis causes iridophore and melanophore loss in zebrafish
embryos (White et al., 2011), we investigated the function of
mpv17 by administrating dNTPs and pyrimidine precursors to
mpv17−/− mutants, and found significant impairment of
Dihydroorotate dehydrogenase (Dhodh) activity in mutants.
RESULTS
Mpv17 and its paralogue, Mpv17-like2, crosstalk
inmpv17−/− larvae
Because zebrafish mpv17 null mutants are viable and fertile, we
verified whether mpv17 paralogue genes might play compensatory
activities in mpv17−/− mutants, thus ameliorating their phenotype.
By performing reverse transcription and quantitative polymerase
chain reaction (RT-qPCR) analysis, we observed a significant
overexpression of mpv17-like2 (mpv17l2), whereas the mpv17-like
(mpv17l) expression level remained unchanged in both wild-type
and homozygous knockout (KO) larvae at 6 days post-fertilization
(dpf ) (Fig. 1A). This result was also confirmed by in situ
hybridization (ISH), which showed wider mpv17l2 expression in
mpv17−/− mutant larvae at 3 dpf, compared with the liver-specific
localization observed in wild-type controls (Fig. S1). Hence, we
checked whether mpv17l2 transcripts might rescue the mpv17 null
mutant phenotype, and thus whether their protein functions could
overlap. To this aim, we injected one-cell-stage embryos with
Fig. 1. Investigation of mpv17 orthologue and paralogue genes in zebrafish larvae. (A) Real-time PCR quantification of mRNA transcripts of mpv17-like2
and mpv17-like at 6 dpf (n=9). (B) Evaluation of phenotypic rescue in the tail region at 3 dpf after the injection of human MPV17 mRNAs, wild-type (WT) and
p.R50Q mutated forms, and zebrafish mpv17 and mpv17-like2 mRNAs. Arrowheads point to iridophores. Scale bars: 100 µm. (C) Relative quantification of
iridophore amount in controls and injected larvae (n=30). (D) mtDNA copy number analysis in mpv17−/− mutants transiently overexpressing mpv17-like2 at
3 dpf and 6 dpf. Mean dCt values were calculated as Ct of mt-nd1 (mitochondrially encoded gene) minus Ct of polg (nuclear gene) (n=4). Statistical analyses
were performed using two-tailed Student’s t-test. Statistical significance was evaluated by setting a confidence interval of 95%; data are mean±s.e.m.
****P<0.0001; ***P<0.001; *P<0.05; ns, not significant. Experiments were performed in biological replicates.
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mRNAs encoding zebrafishmpv17 andmpv17l2, and wild-type and
p.R50Q humanMPV17 (Fig. 1B), and evaluated iridophore number
at 3 dpf. Early phenotyping of mpv17−/− zebrafish mutants can be
easily performed with the aid of a microscope equipped with two
polarizing filters and using the birefringence property of
iridophores. Briefly, embryos are anaesthetized, flat oriented
along the lateral axis and placed above the polarizer lens in a
transmitted-light-dissecting microscope. Then, according to
published protocols for birefringence analysis (Smith et al.,
2013), the polarization plan of the analyser lens, placed above the
sample, is oriented at 90° with the polarizer. With this procedure,
the light from the background is completely abolished, leaving a
black surround. This application of birefringence, in contrast with
Krauss et al. (2013), allows the precise counting of iridophore
number independently from the orientations of light and samples
(Fig. S2). In particular, iridophores are readily visible at 3 dpf; they
are the first metamorphic chromatophores to become observable in
the dermis of the lateral trunk, and appear only later in the anterior
trunk in a segmental fashion, continuing to increase in number and
to accumulate to form the first ventral interstripe (Higdon et al.,
2013; Frohnhöfer et al., 2013).
Interestingly, in all injected samples, except for p.R50Q-injected
larvae, we could observe a significant and comparable increase in
the number of iridophores. Notably, injection of mRNA encoding
the human p.R50Q mutation had a significantly lower effect on the
amount of iridophores (Fig. 1C). Hence, we performed an mtDNA
copy number analysis on mpv17l2-injected embryos and found a
non-significant increase in mtDNA content at 3 dpf (Fig. 1D).
Together, these data show that mpv17 and mpv17l2 functions
may partially overlap, and demonstrate a similar function for human
and zebrafish mpv17, confirming roy as a sound model for
investigating mpv17 roles.
Loss of Mpv17 alters mitochondrial ultrastructure and
respiratory complex stability
MPV17-related MDS primarily show hepatic manifestations and
patients die of liver failure between 6 and 28 months of age (Kim
et al., 2016). To characterize the mpv17−/− mutant phenotype, we
investigated the liver mitochondrial morphology ofmpv17−/− larvae,
by transmission electron microscopy (TEM) analysis. Results
showed a tissue-specific disruption of mitochondrial ultrastructure
in liver hepatocytes at 6 dpf, with mitochondrial ballooning and
disappearance of cristae (Fig. 2A); this phenotypewas absent at 3 dpf
and no difference was detected in brain and muscle tissues (data not
shown). In order to assess whether an impairment of mitochondrial
morphology might modify the amount of mitochondria in the liver,
we crossed mpv17−/− mutants with two different transgenic lines
expressing, respectively, a ubiquitous mitochondrially targeted
enhanced green fluorescent protein (EGFP) and a cytosolic red
fluorescent protein (dsRed) under the control of a hepatic promoter.
In this way, we could analyse mitochondria only where the red
fluorescencewas decorating the liver.When comparing heterozygous
and homozygous siblings at 6 dpf and 12 dpf (Fig. 2B), we did not
observe any difference in the total volume of hepatocytes (data not
shown) and liver mitochondria (Fig. 2C).
To understand whether loss of mitochondrial normal morphology
in mpv17 KO mutants was affecting respiratory complexes (RCs),
we performed an in vivo analysis of the oxygen consumption rate
(OCR) in 4 dpf larvae (Fig. 3A). We detected a significant reduction
in the basal respiration level in mpv17−/− mutants compared with
wild type (Fig. 3B), thus confirming the impairment of oxidative
phosphorylation (OXPHOS) in larvae lacking Mpv17. To enquire
whether the RC dysfunction observed was due to a depletion of
OXPHOS subunits and complexes, we performed a western blot
analysis (Fig. 3C). The cellular amount of all investigated subunits
of RC complexes was lower in mpv17−/− mutants (Fig. 3D); the
nuclear-encoded Uqcrc2b, a subunit of complex III, appeared the
most affected.
To test whether mtDNA depletion was the cause of the observed
reduction in OXPHOS complexes, we assessed mtDNA copy
number in mpv17 homozygous mutants by performing RT-qPCR
analysis of DNA extracted from whole larvae. Surprisingly, for a
MDS gene, we could not find a significant reduction in mtDNA
content in mpv17−/− larvae at 6 dpf, a time point at which the
morphological and respiratory phenotypes were already noticeable
Fig. 2. Analysis of mitochondrial ultrastructure and volume in mpv17−/−
and wild-type liver at 6 dpf. (A) TEM analysis of wild-type (a) and mpv17−/−
liver hepatocytes (b) (n=3). Scale bars: 2 µM. (B) Confocal images of
double Tg(COXVIII-mls:EGFP); Tg(lfabp:dsRed) mpv17+/? and mpv17−/−
siblings at 6 dpf (n=13) and 12 dpf (n=8). Scale bars: 50 µm. (C) Relative
quantification of integrated density. Statistical analyses were performed
using two-tailed Student’s t-test. Statistical significance was evaluated by
setting a confidence interval of 95%; data are mean±s.e.m. ns, not significant.
Experiments were performed in biological replicates.
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(Fig. 3E). However, in 10 dpf mpv17−/− larvae, we did detect a
significant decrease in mtDNA content, thus validating the
zebrafish mpv17 KO mutant as a model for MPV17-related MDS.
To test whether the OXPHOS reduction was due to defective gene
transcription, we investigated, by RT-qPCR, the expression levels of
a nuclear- and a mitochondrial-encoded subunit of complex III. No
difference was observed in nuclear and mitochondrial transcription
when comparing wild-type and mpv17−/− KO larvae at 6 dpf
(Fig. 3F). From these analyses, we can conclude that OXPHOS
complex reduction is not due to a defective transcription. Rather,
mitochondrial cristae disruption impairs supercomplex localization
and functionality (Stuart, 2008), leading to a defective assembly/
stability or translation of respiratory complexes.
Finally, to investigate a possible activation of stress response
machinery inmpv17−/−mutant mitochondria, we focused on Grp75
(also known as Hspa9), a well-studied cytoprotective factor against
oxidative stress (Kaul et al., 2007). Using western blot technique,
we found a significant increase in Grp75 in mpv17 KO mutants
compared with wild type at 6 dpf (Fig. 4A). In addition, knowing
that the mitochondrial contact site and cristae organizing system
(MICOS) acts as a membrane-shaping and -connecting scaffold
(Schorr and van der Laan, 2018), we tested whether the loss of
Fig. 3. Biochemical and genetic characterization of mitochondrial phenotype of mpv17 KO larvae. (A) Basal OCR was measured for ∼1 h in fish water,
immediately after 4 dpf larvae were exposed to 0.5 μM FCCP and, later, to a combination of 2 μM rotenone (Rot) and 5 μM antimycin (AA). Four independent
experiments were performed (n=40). (B) Quantification of basal respiration in wild-type and mpv17−/− mutants (n=40). (C) Protein blot analysis of different
subunits of OXPHOS complexes. (D) Relative quantification of protein amount, using an antibody against βActin for standardization (n=3). R.I., relative intensity.
(E) Relative quantification of mtDNA copy number in wild type and mpv17 homozygous mutants. Mean dCt values were calculated as Ct of mt-nd1
(mitochondrially encoded gene) minus Ct of polg (nuclear gene) and plotted with s.e.m. (n=7). (F) Real-time PCR quantification of mRNA transcripts from
Ubiquinol-cytochrome c reductase complex subunits (n=6). Statistical analyses were performed using two-tailed Student’s t-test. Statistical significance was
evaluated by setting a confidence interval of 95%; data are mean±s.e.m. ****P<0.0001; **P<0.01; *P<0.05; ns, not significant. Experiments were performed in
biological replicates.
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mitochondrial ultrastructure might activate the quality control
system of the organelle. Thus, we checked, by RT-qPCR, the
expression levels of several MICOS subunits: mic13, mic19a,
mic19b andmic60.As a result, we detected a specific transcriptional
upregulation of mic19a in mpv17 KO larvae at 6 dpf (Fig. 4B).
The pyrimidine de novo synthesis pathway is strictly linked
to the iridophore phenotype inmpv17 null mutants
By performing a bioinformatics search on CORD platform to
identify MPV17 co-regulated genes, we found that the trifunctional
Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase and
dihydroorotase (CAD) enzyme involved in pyrimidine production
showed 66.48% of concordance in 176 experiments (Pearson
coefficient 0.504 and P=1.1×10−28), among the highest scores for
MPV17 co-regulated genes (Fig. S3). Remarkably, evidence of a
possible connection between pyrimidine de novo pathway and the
mpv17 mutant phenotype also comes from previous studies: the
inhibition of Dhodh by leflunomide treatment is shown to affect
iridophore and melanophore formation in zebrafish (White et al.,
2011). In addition, by considering previous studies that suggest a
role for Mpv17 in mitochondrial dNTP availability (Löllgen and
Weiher, 2014), we decided to treat mpv17−/− embryos at 8 h post-
fertilization (hpf) with different deoxynucleotide mixtures and to
check the amount of iridophores at 3 dpf. Treating the embryos with
a solution containing all dNTPs was able to increase iridophore
number (Fig. 5A), and dUTP administration had the best effect in
ameliorating the mpv17 KO phenotype (Fig. 5B).
Consequently, we decided to investigate whether the
mitochondrial step of pyrimidine de novo synthesis was
affected in mpv17 mutants. The conversion of dihydroorotic
acid (DHOA) into orotic acid (OA) is a metabolic reaction
catalysed by Dhodh, the only mitochondrial enzyme involved in
pyrimidine de novo synthesis. Hence, we hypothesized that
Dhodh functionality might be partially impaired in mpv17 null
mutants. Notably, in accordance with the results by White et al.
(2011), we found a specific effect of leflunomide on iridophore
formation at low doses; melanophores correctly develop,
confirming that inhibition of Dhodh significantly impairs
iridophore growth at 3 dpf (Fig. 5C,D).
OA treatment restores iridophore formation and increases
mtDNA copy number inmpv17 null mutants
To test a connection between Dhodh impairment and the mpv17
mutant phenotype, we assessed Dhodh activity by performing a
histochemistry assay on liver cryosections of wild-type andmpv17−/−
adults. We decided to perform this analysis on hepatic tissue
because Dhodh is highly active in liver, as reported by Löffler et al.
(1996), and also because we had found a severe disruption of
hepatic mitochondria in mpv17 KO larvae. Interestingly, we
observed significantly lower Dhodh enzymatic activity in mpv17
null mutants compared with wild type, an activity similar to that of
leflunomide-treated samples (Fig. 6A). The biochemical assay
confirmed Dhodh impairment in the lysate of mpv17 KO larvae at
6 dpf (Fig. 6B). In particular, the specific activity of Dhodh in wild
type (average value 4534 nmol/min per mg protein), highly similar
to that measured in rat liver by Löffler et al. (1996), decreased to
20% in mpv17 null mutant larvae (average value of 1848 nmol/min
per mg protein). These results highlight that the functionality
of Dhodh mitochondrial enzyme is reduced at early stages of
development and indicate that the impairment of Dhodh enzymatic
activity might be the main cause of premature loss of iridophores in
mpv17 null mutants.
In order to examine in vivo the mitochondrial reaction of the
pyrimidine metabolic pathway, we tested whether administration of
OA, the product of Dhodh reaction, might rescue the mpv17−/−
mutant phenotype (Fig. S4A). When OAwas injected into the yolk
sac of 20 hpf embryos we could observe a clear rescue of
iridophores in mpv17 null larvae at 3 dpf (Fig. 6C). In addition,
while mpv17 mutants displayed a constant, although non-
significant, decrease in mtDNA copy number at 3 dpf, mpv17−/−
larvae treated with OA exhibited increased mtDNA copy number,
with no effect on heterozygotes (Fig. 6D).
Finally, we tested the effect of DHOA (the substrate of Dhodh
enzyme) in mpv17 mutants. As expected, L-DHOA injected at
20 hpf into mpv17 mutant embryos had no effect on the phenotype,
thus confirming Dhodh deficiency in mpv17 null mutants (Fig. 6E;
Fig. S4B).
Fig. 4. Evaluation of stress response and mitochondrial quality control
system in zebrafish larvae. (A) Representativewestern blot analysis of Grp75
protein from 6 dpf zebrafish larvae and relative quantification, using an
antibody against Tomm20 (also known as Tomm20b) for standardization
(n=3). (B) Real-time PCR quantification of mRNA transcripts from different
MICOS subunits at 6 dpf (n=8). Statistical analyses were performed using two-
tailed Student’s t-test. Statistical significance was evaluated by setting a
confidence interval of 95%; data are mean±s.e.m. ***P<0.001; **P<0.01; ns,
not significant. Experiments were performed in biological replicates.
5
RESEARCH ARTICLE Disease Models & Mechanisms (2019) 12, dmm037226. doi:10.1242/dmm.037226
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
DISCUSSION
Our work validates roy as a model for investigating the role of
mpv17 and a powerful tool for developing new therapeutic strategies
against MPV17-related MDS. First, as already reported by D’Agati
et al. (2017), we confirmed that zebrafish mpv17 mRNA can rescue
thempv17−/−mutant phenotype, and, most importantly, that human
MPV17mRNA also has similar properties in vivo, thus supporting a
conserved function of the two orthologues; this finding is also in
agreement with complementation assays in the yeast sym1Δ model
(Trott and Morano, 2004), showing a functional link between Sym1
and mammalian MPV17. In addition, a recent work demonstrated
that the growth of sym1Δ strain transformed with R51Q (hR50Q)
mutant Sym1-HA allele was impaired (Gilberti et al., 2018). In
agreement, also in zebrafish, the injection of the p.R50Q mutated
form of human MPV17 mRNA resulted in a mild rescue of the
mpv17−/− KO phenotype.
Considering that mutants showing minor phenotypical features
might exhibit a compensatory upregulation of other members of
the gene family (Rossi et al., 2015), we investigated possible
feedback mechanisms acted by mpv17 paralogous genes, also
considering that both paralogous proteins (MPV17L and
MPV17L2) were previously reported to be mitochondrial
proteins (Dalla Rosa et al., 2014; Krick et al., 2008). We could
observe increased expression of mpv17l2 in mpv17 null mutants.
Moreover, overexpression of Mpv17L2 was able to rescue the
chromatophore phenotype of mpv17−/− mutants. These results
support the idea of partial overlapping cellular functions for
Mpv17 and Mpv17l2, at least in zebrafish. This finding contrasts
with a previous work, carried out in human cellular models, that
proposes different roles for MPV17, claimed to be involved in purine
synthesis (Dalla Rosa et al., 2016), and MPV17L2, suggested to play
a role in mitochondrial ribosome assembly (Dalla Rosa et al., 2014).
On the other hand, the tissue-restricted mpv17l2 overexpression we
detected was not able to prevent the strong mitochondrial phenotype
assessed in mpv17 zebrafish mutants. Thus, the role of mpv17l2 in
mitochondria is still an open question. In addition, we did not observe
any significant effect of mpv17l2 mRNA injection on the mtDNA
stability of mpv17 KO larvae. A possible explanation is the lack of
significant mtDNA replication, unnecessary at early stages of
development (Artuso et al., 2012), thus hampering the evaluation
of the role of mpv17l2 at these time points. Because of that, stable
lines overexpressing mpv17l2 in an mpv17−/− mutant background
might be useful tools to follow its effect at later stages of
development. Moreover, it is important to underline that the
injection of mpv17l2 mRNA leads to non-physiological and
ubiquitous expression of Mpv17l2, which is normally not
expressed in neural-crest-derived cells, but rather restricted to liver
tissue and the digestive system at later stages (Thisse and Thisse,
2004) (Fig. S1). This tissue-specific expression of mpv17l2might be
the reason why mpv17 KO mutants, although showing significant
overexpression of mpv17l2, still lack iridophores, while they do not
display any overt hepatic defect at the anatomical level.
In the past two decades, different MPV17-related MDS models
have been developed, all showing phenotypes that are only partially
representative of human clinical features. Whereas the Mpv17 KO
mouse strain mainly shows glomerulosclerosis and inner ear defects
(Löllgen and Weiher, 2014), the zebrafish mpv17 null mutant
phenotype is mostly characterized by a specific lack of iridophores
Fig. 5. Investigation of dNTP metabolism in zebrafish larvae. (A) Visualization of iridophores in the tail region of 3 dpf larvae treated with different
mixtures of dNTPs. (B) Relative quantification of iridophore number (n=27). (C) Wild-type embryos were treated with dimethyl sulfoxide and 2 μM leflunomide,
inhibitor of pyrimidine biosynthesis. Whole-body bright-field pictures (a,b) and birefringent images of the tail region (c,d) are shown. (D) Quantification of relative
amounts of iridophores (n=27). Arrowheads point to iridophores. Scale bars: 100 µm. Statistical analyses were performed using two-tailed Student’s t-test.
Statistical significance was evaluated by setting a confidence interval of 95%; data are mean±s.e.m. ****P<0.0001; ***P<0.001; **P<0.01. Experiments
were performed in biological replicates.
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and a progressive loss of melanophores, both derived from the
neural crest. This phenotype perfectly matches theMpv17−/−mouse
premature greying (Viscomi et al., 2009) and the progressive
demyelinating peripheral neuropathy found in 38% of MPV17
mutant patients (El-Hattab et al., 2018), features that we can
consider possible neurocristopathies.
Notably, in this work, we demonstrate that zebrafish mpv17
mutant larvae display a severe mitochondrial phenotype,
characterized by disappearance of mitochondrial cristae in liver
hepatocytes, impairment and reduction of RC complexes, mtDNA
depletion and activation of mitochondrial stress response.
Alterations of the mitochondrial ultrastructure were previously
found inMpv17KOmouse liver (Viscomi et al., 2009) and in a yeast
sym1Δ model (Dallabona et al., 2010). Moreover, Dallabona and
colleagues also suggested that Sym1 is primarily involved in
mitochondrial ultrastructure maintenance (Dallabona et al., 2010),
taking into account that the loss of cristae architecture affects
mtDNA stability and supercomplex arrangement within inner
mitochondrial membrane (Stuart, 2008). Our findings strongly
support this hypothesis as we were able to observe a significant
reduction in mtDNA copy number only at 10 dpf, while
mitochondrial ultrastructure and RC complexes were already
impaired at 6 dpf. Moreover, a tissue-specific dysfunction in
OXPHOS complexes is frequently found in patients affected by
different mutations in the MPV17 gene (Spinazzola et al., 2006;
Uusimaa et al., 2014; El-Hattab et al., 2018). Taken together, our
results prove that the mpv17 null mutant perfectly resembles the
human mitochondrial phenotype, thus indicating that roy is a
powerful model for MPV17-related MDS.
Additionally, the overproduction of Grp75 and the overexpression
of mic19a we found in mpv17−/− mutants highlight the importance
of mpv17 in preserving mitochondrial homeostasis, suggesting
that, in the absence of Mpv17, protective mechanisms act
against oxidative stress and loss of mitochondrial morphology.
Interestingly, the grp75 yeast orthologue gene, SSC1, was also
found upregulated at the transcriptional level in the yeast mpv17
orthologue mutant sym1Δ (Trott andMorano, 2004). Moreover, it is
indeed well-established that injured mitochondria trigger ROS
production via further electron escape from impaired electron
transport chain (Maharjan et al., 2014); notably, enhanced ROS
levels were previously reported in mice and cell lines depleted of
MPV17 (Wagner et al., 2005; Shvetsova et al., 2017).
Fig. 6. Analysis of the link between Dhodh functionality and thempv17 KO phenotype. (A) Histochemical Dhodh assay on cryosections of adult wild-type
(a-d) and mpv17 KO (e-h) liver. The activity assay was performed on the same slide and a reaction mix containing 100 μM leflunomide was used as negative
control (c,d,g,h). Pictures were taken at lower (a,c,e,g) and higher (b,d,f,h) magnification. Scale bars: 100 µm (n=3). (B) Dhodh biochemical assay in 6 dpf larvae.
Dhodh was assessed in zebrafish homogenized through spectrophotometric recordings following the reduction of 2,6-dichlorophenolindophenol (DCPIP).
Specific Dhodh activity was obtained by subtracting the leflunomide-independent fraction and measured as nmol/min per mg of protein. Values were then
normalized with respect to wild-type controls. Statistical analysis was performed using paired Student’s t-test (n=3). (C,D) Relative quantification of iridophore
amount in 3 dpf larvae treated with 1 μM orotic acid (OA) (n=36) (C) and mtDNA copy number analysis (n=8) (D). (E) Relative evaluation of iridophore number in
3 dpf larvae treated with 100 μM dihydroorotic acid (DHOA) (n=17). Statistical analyses were performed using two-tailed Student’s t-test. Statistical significance
was evaluated by setting a confidence interval of 95%; data are mean±s.e.m. ****P<0.0001; **P<0.01; ns, not significant. Experiments were performed in
biological replicates.
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MPV17 was discovered about 30 years ago; however, its
function remains unknown. To date, the leading hypothesis is that
MPV17 may represent an inner mitochondrial membrane protein
involved in nucleotide supply for mtDNA synthesis (Löllgen and
Weiher, 2014). As for other MDS-related mutations, MPV17
mutations might impair deoxyribonucleotide metabolism, leading to
limited dNTP availability and subsequent mtDNA depletion. Indeed,
administration of dNTPs is a therapeutic strategy for treatment of
MDS-like mitochondrial neurogastrointestinal encephalopathy
(MNGIE) syndrome (Cámara et al., 2014). It was previously
reported that supplementation with different amino acids, all
precursors in the synthesis of nucleotides, partially restored aerobic
oxidative growth in the yeast sym1Δ strain (Dallabona et al., 2010).
Coherently, we found that deoxyribonucleotide administration
strongly increased iridophore number in mpv17−/− larvae. In
particular, because dUTP showed the best effect, we focused on
pyrimidine de novo synthesis. Serendipitously, by performing a
bioinformatics analysis, we found that MPV17 and CAD, a cytosolic
enzyme involved in pyrimidine production, are highly co-regulated.
Moreover, we observed that a mild inhibition of Dhodh enzyme
specifically impaired iridophore development and that Dhodh activity
is significantly reduced in mpv17−/− mutants, in agreement with the
well-established link between theDhodh-mediated mitochondrial step
of pyrimidine production and neural crest cell formation (White et al.,
2011). Finally, administration of OA, but not DHOA, significantly
rescued the phenotype ofmpv17−/− larvae. Taken all together, our data
indicate insufficient pyrimidine synthesis and impairment of Dhodh in
mpv17−/− null mutants, possibly the cause of their main phenotypical
trait. Whether this is due to the disruption of mitochondrial cristae, in
which the enzyme is located, or to a possible interaction between
Dhodh andMpv17, needs to be further investigated.Most remarkably,
the ability of OA (considered in the past vitamin B13) to increase
mtDNA content inmpv17KOmutants, the availability of this nutrient
in dairy products and its current use as a food supplement open new
opportunities in the treatment of MPV17-related MDS, to date a
disease with poor prognosis and no cure yet available.
MATERIALS AND METHODS
Zebrafish husbandry and maintenance
All experiments were performed in accordance with the European and
Italian Legislations and with permission for animal experimentation from
the Local Ethics Committee of the University of Padova. Danio rerio
(zebrafish) were maintained in a temperature-controlled (28.5°C)
environment and fed as described by Kimmel et al. (1995). The roy strain
was originally obtained from the Harvard Medical School (Boston, USA),
and genotyping at early stages was performed by PCR with the following
primers: forward, 5′-AACCGTTTGTCATAATGTGGC-3′; reverse-wt,
5′-CATGGGTGTTTGGCCATCAG-3′; reverse-del, 5′-ACATCAACT-
ACATGGGTGGG-3′.
For in vivo studies, the following transgenic lines, crossed with roy, were
used: Tg(lfabf:dsRed; elaA:EGFP), generated by Korzh et al. (2008);
Tg(COXVIII-mls:EGFP), generated in our laboratory by N.F., using a
construct kindly provided by the Seok-Yong laboratory (Chonnam National
University Medical School, Gwangju, Republic of Korea), containing the
mitochondrial localization sequence of subunit VIII of human cytochrome c
oxidase (COXVIII; also known as COX8A).
RNA extraction and RT-qPCR
Total mRNAwas isolated from50 larvae using Trizol (Invitrogen) and reverse-
transcribed using SuperScript® III First-Strand (Thermo Fisher Scientific).
Quantitative PCR (qPCR) was performed using a Rotor-gene Q (Qiagen) and
5×HOTFIREPol®EvaGreen® qPCRMixPlus (SolisBioDyne), following the
manufacturers’ protocols. The cycling parameters were 95°C for 14 min,
followed by 45 cycles at 95°C for 15 s, 59°C for 25 s and 72°C for 20 s.
Threshold cycles (Ct) and dissociation curves were generated automatically by
Rotor-Gene Q series software. Primer sequences are listed in Table 1. Sample
Ct values were normalized with Ct values from zebrafish gapdh.
Whole-mount ISH
According to Thisse and Thisse (2004), the full-length sequence of mpv17l2
(ENSDARG00000056367) was PCR amplified from liver complementary
DNA (cDNA) of adult zebrafish, using the following primers, designed
by Primer3 software (http://primer3.ut.ee): mpv17l2 probe-F, 5′-CGACT-
CATGTTGGCTGCTC-3′; mpv17l2 probe-R, 5′-GCCCAGCGTATGT-
CACAAAT-3′. The PCR products were purified, then cloned into pCR2.1
TOPO vector (TOPO TA Cloning Dual Promoter Kit, Stratagene) and
sequence verified. For riboprobe in vitro transcription, the constructs were
linearized with the appropriate endonuclease enzyme (Promega) and
transcribed with DIG-labelling mix and RNA polymerase (Roche): for
antisense (working) riboprobe, HindIII/T7 RNApol; for sense (negative
control) probe, NotI/SP6 RNApol. Whole-mount ISH was performed on
zebrafish larvae at 3 dpf, previously fixed with 4% paraformaldehyde (PFA)/
PBS and stored in 100% methanol, following standard protocols. At least 20
larvae per condition were processed in a single tube. For signal comparison,
wild-type control and mpv17−/− mutant larvae were co-processed and co-
stained in the same tube; controls were recognized by tail tip excision,
performed after PFA fixation and before whole-mount ISH.
mRNA rescue
The full-length mpv17 and mpv17l2 cDNAs from wild-type strain and
human MPV17 cDNA from pCR2.1 TOPO vector, kindly provided by
the Zeviani laboratory (University of Cambridge, Cambridge, UK),
were subcloned into the pCS2+ vector. The human MPV17 p.R50Q
(CGG>CAG) mutated form was generated, starting from wild-type
construct, using a Q5® Site-Directed Mutagenesis Kit (New England
Biolabs) and the following primers: forward, 5′-CAGAGAGGCC-
AGACTCTGACCATG-3′; reverse, 5′-GTGTTCCTGCAGACCCCG-3′,
both designed by NEBaseChanger online tool (New England Biolabs).
Capped mRNA was transcribed using the mMessage mMachine® kit
(Thermo Fisher Scientific) according to the manufacturer’s protocol. The
mRNAwas resuspended in water and microinjected into one-cell mpv17−/−
embryos at 70 ng/μl.
Iridophore count
Iridophore number was measured with the aid of two polarizing filters,
basing on the physical property of these cells of being birefringent. Larvae at
Table 1. Zebrafish gene-specific primers used for qPCR analyses
Gene Forward primer Reverse primer
gapdh 5′-GTGGAGTCTACTGGTGTCTTC-3′ 5′-GTGCAGGAGGCATTGCTTACA-3′
uqcrc1 5′-ACTCGGCTCACTACCCTAGA-3′ 5′-TCAAGAGCAGACTGAGGGTG-3′
mic13 5′-CCCTGTCGTCAAGTTTGC-3′ 5′-TCATCCACTCATCCACAG-3′
mic19a 5′-CCTCTTGAATCAGTGGGT-3′ 5′-CGTGAGCCTGAGACTTTT-3′
mic19b 5′-CCTCCATTCCCGATTCCT-3′ 5′-TCTGCCGTCTTCATCTCC-3′
mic60 5′-CGCTGGGAAAATAGTGGC-3′ 5′-TGGTTTGACAGTCTCCGG-3′
mt-cyb 5′-TCTCCACGAAACCGGATCAA-3′ 5′-CTAGAGGGTTAGCAGGGGTG-3′
mpv17l 5′-CCTCACCTTTGGCGACCA-3′ 5′-CCCATGAACGCTGTCCTC-3′
mpv17l2 5′-ATGTTTGCTGTGGGATGCTC-3′ 5′-GCGCCTCAATGAAAGTGTGA-3′
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3 dpf were anaesthetized with tricaine (0.16 mg/ml), placed on a glass, and
the top filter was twisted until it was possible to see the light refracting
through the striated muscle. Birefringence analysis was performed
according to published methods (Smith et al., 2013). Samples were
photographed using a Leica MDG41 microscope and a Nikon Digital Sight
DS Fi2 camera; iridophores were manually counted in the tail region and
their amount was normalized to that of controls.
Relative quantification of mtDNA content in whole larvae
and sections
DNA samples, extracted from 20 pooled larvae or sections at 3, 6 and
10 dpf, were prepared as described by Rahn et al. (2015) and quantified by
PicoGreen assay (Invitrogen) using the Infinite 200 PRO plate reader
(Tecan). Then, 8.5 ng of each samplewas used in a qPCR reaction and run in
triplicate, using 5× HOT FIREPol® EvaGreen® qPCR Supermix (Solis
Biodyne). mtDNA copy number was determined by the RT-qPCR standard
curve method using mt-nd1 as the mitochondrial gene target and the polg
gene as a reference for nDNA, following the protocol developed by Artuso
et al. (2012). The delta Ct (dCt) valuewas calculated by subtracting the Ct of
polg from the Ct of mt-nd1 for each sample.
TEM analysis
Larvae were anaesthetized and fixed with 2.5% glutaraldehyde in 0.1 M
sodium cacodylate buffer, then dehydrated, embedded in epoxy resin and
sectioned following a standard TEM sample preparation protocol. All steps
after fixation were performed by the TEM service of the Department of
Biology (University of Padova).
Confocal analysis and mitochondrial volume measurements
Double transgenic fluorescence of Tg(lfabf:dsRed; COXVIII-mls:EGFP) in
mpv17−/− mutant background was visualized under a Leica M165FC
dissecting microscope and then with a Nikon C2 H600 L confocal
microscope. Larvae were anaesthetized and mounted in 1% low-melting-
point agarose gel. Mitochondrially targeted EGFP and cytosolic dsRed
fluorescence was visualized by using 488 nm and 561 nm lasers, through a
40× immersion objective (Nikon). All images were analysed with Fiji
software (https://fiji.sc/). Mitochondria were automatically segmented on
the EGFP fluorescence image stacks, inside a dsRed fluorescent mask
identifying hepatic tissue, and total mitochondrial volume was calculated,
according to previous work (Facchinello et al., 2016). After confocal
acquisition, heterozygous and homozygous siblings were genotyped by
PCR on DNA previously extracted from a single larva, as described by
Gagnon et al. (2014).
Measurement of OCR
OCR was measured in zebrafish larvae at 96 hpf with a Seahorse XF24
extracellular flux analyser. Larvae were placed into the XF24 microplate
well (one larva per well) and blocked with a capture screen in the presence of
670 μl fish water (0.5 mM NaH2PO4, 0.5 mM NaHPO4, 3 mg/l instant
ocean). Basal respiration was measured for 63 min at 28.5°C, while the
maximal respiration was measured upon administration of 0.5 μM carbonyl
cyanide-4-phenylhydrazone (FCCP). A mixture of 2 μM rotenone (Rot) and
5 μMantimycin Awas added to shut down electron transport chain function,
revealing the non-mitochondrial respiration. Basal respiration was obtained
by subtracting non-mitochondrial respiration. Respiratory rates are the
average±s.e.m. of at least 20 individual larvae per condition.
Western blot analysis
Proteins were extracted from 30 pooled larvae at 6 dpf. Lysis was performed
in ice-cold RIPA buffer [125 mM NaCl, 25 mM Tris-HCl pH 7.4, 1 mM
EGTA-Tris pH 7.4, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1%
SDS and complete EDTA-free protease inhibitor cocktail (Roche)]. Crude
lysate was cleared by centrifuging for 30 min at 15,000 g and proteins in the
supernatant were quantified using a BCA Protein Assay Kit (Pierce). Equal
amounts of proteins (50 μg) were loaded on 4-12% Bis-Tris NuPage gels
(Life Technologies) and blotted on PVDF Immobilon-P membranes
(Millipore). Dried membranes were then washed with TBS buffer
(50 mM Tris-HCl pH 7.5, 50 mM NaCl) with 1% (w/v) bovine serum
albumin (BSA; Sigma-Aldrich) and incubated overnight with the indicated
primary antibodies at 4°C: Mitoprofile® Human WB Total OXPHOS
cocktail antibody (1:100; Abcam, ab110411), anti-Grp75 antibody (1:1000;
Santa Cruz Biotechnology, H-155), anti-Actin antibody (1:1000; Santa
Cruz Biotechnology, AC-15) or anti-Tomm20 antibody (1:10,000; Sigma-
Aldrich, HPA011562). Secondary horseradish-peroxidase-conjugated
antibodies (Bio-Rad) were incubated for 1 h at room temperature and
protein bands were detected by chemiluminescence on a UVITEC Alliance
Mini HD9. Quantitation of the signal was performed with ImageJ software
(https://imagej.nih.gov/ij/).
Compound administration
Deoxynucleotide Set (SLBH8759), OA (O2750) and L-DHOA (D7128)
were obtained from Sigma-Aldrich. dNTPs (12.5 µM each) were added to
embryo medium at 8 hpf, and OA (1 µM) and L-DHOA (100 µM) were
injected into the yolk sac of 20 hpf embryos as described by Willer et al.
(2005). Controls were injected at 20 hpf, with a control solution containing
NaOH or dimethylformamide, and phenotypic rescuewas evaluated at 3 dpf.
Dhodh activity assays
To measure Dhodh activity, 6 dpf larvae were homogenized in a buffer
composed of 100 mMHEPES pH 7.5, 150 mMNaCl, 0.01% Triton X-100,
protease and phosphatase inhibitors. Cell homogenates (60 μg) were pre-
incubated for 10 min with the substrate L-DHOA (10 mM) and alamethicin
(2 mM), and separately with the Dhodh inhibitor leflunomide (200 μM).
After the pre-incubation time, sodium azide (250 mM), antimycin A
(2 mM), rotenone (2 mM), 3-nitropropionic acid (2 mM), Coenzyme Q1
(10 mM) and 2,6-dichlorophenolindophenol (DCPIP; 5 mM) were added.
Dhodh activity was assessed at 30°C through spectrophotometric recordings
following the reduction of DCPIP at 600 nM (ε=19.1×mM−1×cm−1).
Values were normalized for protein amount.
Dhodh enzymatic activity was also histochemically assessed on frozen
tissue. The sections were incubated for 30 min at 37°C with a medium
containing HEPES (150 mM) pH 8, L-DHOA (10 mM), sodium azide
(1 mM) and Nitro Blue Tetrazolium (NBT) (1 mM). The Dhodh inhibitor
leflunomide (200 µm) was included in the test. Successively, the sections
were rinsed with a wash solution containing HEPES (150 mM) pH 8 and
water and covered using a mounting medium. The DHOA was oxidized to
OA, producing FMNH2, and the reaction was visualized by chemically
reacting the electron acceptor with the purple salt NBT. Samples were
photographed using a Leica DMR microscope equipped with a Leica
DFC7000T digital camera.
Statistics
Prism software (GraphPad) was used for data analysis and figure plotting.
All experiments were performed at least in biological triplicate. Standard
error of the mean calculations and all statistical analyses were performed
using Student’s t-test.
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9
RESEARCH ARTICLE Disease Models & Mechanisms (2019) 12, dmm037226. doi:10.1242/dmm.037226
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
di Padova, Neurofibromatosis (Therapeutic Acceleration Program) and
Associazione Italiana per la Ricerca sul Cancro (IG 2017/20749).
Supplementary information
Supplementary information available online at
http://dmm.biologists.org/lookup/doi/10.1242/dmm.037226.supplemental
References
Artuso, L., Romano, A., Verri, T., Domenichini, A., Argenton, F., Santorelli, F. M.
and Petruzzella, V. (2012). Mitochondrial DNA metabolism in early development
of zebrafish (Danio rerio). Biochim. Biophys. Acta 1817, 1002-1011.
Calvo, S. E., Clauser, K. R. and Mootha, V. K. (2016). MitoCarta2.0: an updated
inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 44,
D1251-D1257.
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